Literature DB >> 19837168

Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability.

Silvia De Rubeis1, Claudia Bagni.   

Abstract

The fragile X mental retardation protein (FMRP) is an RNA binding protein that has an essential role in neurons. From the soma to the synapse, FMRP is associated with a specific subset of messenger RNAs and controls their posttranscriptional fates, i.e., dendritic localization and local translation. Because FMRP target mRNAs encode important neuronal proteins, the deregulation of their expression in the absence of FMRP leads to a strong impairment of synaptic function. Here, we review emerging evidence indicating a critical role for FMRP in the control of mRNA stability. To date, two mRNAs have been identified as being regulated in this manner: PSD-95 mRNA, encoding a scaffolding protein, and Nxf1 mRNA, encoding a general export factor. Moreover, expression studies suggest that the turnover of other neuronal mRNAs, including those encoding for the GABA(A) receptors subunits, could be affected by the loss of FMRP. According to the specific target and/or cellular context, FMRP could influence mRNA stability in the brain. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837168     DOI: 10.1016/j.mcn.2009.09.013

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  60 in total

1.  Delayed stabilization of dendritic spines in fragile X mice.

Authors:  Alberto Cruz-Martín; Michelle Crespo; Carlos Portera-Cailliau
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 3.  The trouble with spines in fragile X syndrome: density, maturity and plasticity.

Authors:  C X He; C Portera-Cailliau
Journal:  Neuroscience       Date:  2012-04-20       Impact factor: 3.590

4.  Fragile X mental retardation protein levels are decreased in major psychiatric disorders.

Authors:  S Hossein Fatemi; Rachel E Kneeland; Stephanie B Liesch; Timothy D Folsom
Journal:  Schizophr Res       Date:  2010-08-19       Impact factor: 4.939

5.  A Requirement for Mena, an Actin Regulator, in Local mRNA Translation in Developing Neurons.

Authors:  Marina Vidaki; Frauke Drees; Tanvi Saxena; Erwin Lanslots; Matthew J Taliaferro; Antonios Tatarakis; Christopher B Burge; Eric T Wang; Frank B Gertler
Journal:  Neuron       Date:  2017-07-20       Impact factor: 17.173

6.  TARGETED TREATMENTS IN AUTISM AND FRAGILE X SYNDROME.

Authors:  C Kağan Gürkan; Randi J Hagerman
Journal:  Res Autism Spectr Disord       Date:  2012-10-01

7.  Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function.

Authors:  Helen S Bateup; Kevin T Takasaki; Jessica L Saulnier; Cassandra L Denefrio; Bernardo L Sabatini
Journal:  J Neurosci       Date:  2011-06-15       Impact factor: 6.167

Review 8.  Consensus paper: pathological role of the cerebellum in autism.

Authors:  S Hossein Fatemi; Kimberly A Aldinger; Paul Ashwood; Margaret L Bauman; Charles D Blaha; Gene J Blatt; Abha Chauhan; Ved Chauhan; Stephen R Dager; Price E Dickson; Annette M Estes; Dan Goldowitz; Detlef H Heck; Thomas L Kemper; Bryan H King; Loren A Martin; Kathleen J Millen; Guy Mittleman; Matthew W Mosconi; Antonio M Persico; John A Sweeney; Sara J Webb; John P Welsh
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

9.  Dendritic transport of tick-borne flavivirus RNA by neuronal granules affects development of neurological disease.

Authors:  Minato Hirano; Memi Muto; Mizuki Sakai; Hirofumi Kondo; Shintaro Kobayashi; Hiroaki Kariwa; Kentaro Yoshii
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

10.  MDM2 inhibition rescues neurogenic and cognitive deficits in a mouse model of fragile X syndrome.

Authors:  Yue Li; Michael E Stockton; Ismat Bhuiyan; Brian E Eisinger; Yu Gao; Jessica L Miller; Anita Bhattacharyya; Xinyu Zhao
Journal:  Sci Transl Med       Date:  2016-04-27       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.